Status:
UNKNOWN
Excitability Protocol: Voltage-gated Ion Channels
Lead Sponsor:
Aalborg University
Conditions:
Pain
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of subproject 1 is to evaluate the accuracy of a nerve excitability protocol in healthy subjects before testing the protocol in diabetic neuropathy patients. The nerve excitability protoco...
Eligibility Criteria
Inclusion
- Healthy men and women in the age 18-80 years who speak and understand English.
Exclusion
- Pregnancy or breast feeding
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Previous and present neurologic, musculoskeletal or mental illnesses (e.g., epilepsy, neuropathy, fibromyalgia and depression)
- Skin diseases
- Past history of conditions possibly leading to neuropathy
- Inability to cooperate
- Current use of medications that may affect the study, e.g., analgesics
- Previous traumatic experience of an electrical accident
- Consumption of alcohol or painkillers within the last 24 hours
- Participation in other pain studies throughout the study period
- Patients with cardiac diseases (e.g., pacemaker).
Key Trial Info
Start Date :
July 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05368532
Start Date
July 31 2022
End Date
March 1 2024
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University
Aalborg, Denmark, 9000